SC2.0 More Details »
Click for More...
The world first witnessed the power of vaccination with Edward Jenner’s demonstration of smallpox inoculations more than two centuries ago, yet strides are still being made in the field to this day. Once the crude transfer of material from an affected individual with the hopes of conferring protection through mild exposure, the field has grown to nearly eradicate many of the infectious diseases threatening our species including smallpox, diphtheria, whooping cough, measles, and tuberculosis to name just a few. Contemporary vaccine development and research now turns its focus towards the worlds worst biological threats such as HIV, malaria, and even cancer. GenScript’s vaccine development related services provide cutting edge support to accelerate vaccine research from gene synthesis through animal models.
Fast de novo synthesis for granular control of immune response, RNA and protein stability, and recombination risk.
Increase target expression for sufficient immune stimulation or rationally deoptimize critical viral genes to protect against viral infections. Learn more
High level expression platform for proteins or protein subunits (antigens) that don’t require post-translational modification.
Mammalian transient and stable expression services deliver high quality proteins and recombinant antibodies (rAbs) from microgram to gram quantities.
Precisely direct optimal immunogenic responses with peptide level accuracy
Screen for immunogenicity and relevant epitopes with focused, yet high throughput capacity
Predict patient efficacy and inform vaccine design.
Seamlessly streamline transition into preclinical testing in animal models using peptide, protein and gene as the vaccine in multiple dosing routes.
Please contact us if you need immediate assistance.
Please contact us (phone: 1-877-436-7274 or email: firstname.lastname@example.org),if you need immediate assistance.